Jochen Huber

Title: Jochen Huber: Innovator in Gene Expression Inhibition

Introduction

Jochen Huber is a notable inventor based in Maxdorf, Germany. He has made significant contributions to the field of gene expression inhibition, holding a total of 6 patents. His work focuses on innovative oligonucleotide derivatives that have the potential to advance genetic research and therapeutic applications.

Latest Patents

Among his latest patents, Huber has developed synthetic double-stranded oligonucleotides for specific inhibition of gene expression. This invention relates to oligonucleotide derivatives that are at least partly double-stranded and feature a 2'5′-linked oligonucleotide residue on at least one 3′ end. These derivatives are designed for targeted inhibition of gene expression. Another significant patent involves oligoribonucleotide derivatives for specific inhibition of gene expression. This invention pertains to oligoribonucleotide derivatives that possess a 2'5′-linked oligoribonucleotide residue without a 5′-phosphate residue on the 3′ end, also aimed at specific gene expression inhibition.

Career Highlights

Throughout his career, Jochen Huber has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH. His experience in these organizations has contributed to his expertise in the development of innovative genetic solutions.

Collaborations

Huber has collaborated with notable colleagues such as Eugen Uhlmann and Niki Gunkel. These partnerships have likely enhanced his research and development efforts in the field of gene expression.

Conclusion

Jochen Huber's contributions to the field of gene expression inhibition through his innovative patents and collaborations highlight his role as a significant inventor in biotechnology. His work continues to pave the way for advancements in genetic research and therapeutic applications.